You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Upadhyaya P, Hurov K, Kublin J, et al
706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0706